The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.

M K Steuer-Vogt; Viktor Bonkowsky; P Ambrosch; M Scholz; A Neiss; J Strutz; M Hennig; T Lenarz; W Arnold

doi:10.1016/S0959-8049(00)00360-9

The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.

M K Steuer-Vogt, Viktor Bonkowsky (Co-author), P Ambrosch, M Scholz, A Neiss, J Strutz, M Hennig, T Lenarz, W Arnold

Research output: Contribution to journal › Original Article › peer-review

93 Citations (Web of Science)

Original language	English
Pages (from-to)	2-31
Journal	EUROPEAN JOURNAL OF CANCER
Volume	37
Issue number	1
DOIs	https://doi.org/10.1016/S0959-8049(00)00360-9
Publication status	Published - 2001

Keywords

GALACTOSIDE-SPECIFIC LECTIN
BETA-ENDORPHIN RELEASE
ALTERNATIVE MEDICINE
COMPLEMENTARY/ALTERNATIVE MEDICINE
LYMPHOCYTE SUBSETS
EXTRACT
CELLS
CARCINOMAS
PREVALENCE
MEDIATE

Access to Document

10.1016/S0959-8049(00)00360-9

Cite this

Steuer-Vogt, M. K., Bonkowsky, V., Ambrosch, P., Scholz, M., Neiss, A., Strutz, J., Hennig, M., Lenarz, T., & Arnold, W. (2001). The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. EUROPEAN JOURNAL OF CANCER , 37(1), 2-31. https://doi.org/10.1016/S0959-8049(00)00360-9

Steuer-Vogt, M K ; Bonkowsky, Viktor ; Ambrosch, P et al. / The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. In: EUROPEAN JOURNAL OF CANCER 2001 ; Vol. 37, No. 1. pp. 2-31.

@article{9c7820e05ec74fa793e1dccbd52ca5db,

title = "The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.",

keywords = "GALACTOSIDE-SPECIFIC LECTIN, BETA-ENDORPHIN RELEASE, ALTERNATIVE MEDICINE, COMPLEMENTARY/ALTERNATIVE MEDICINE, LYMPHOCYTE SUBSETS, EXTRACT, CELLS, CARCINOMAS, PREVALENCE, MEDIATE",

author = "Steuer-Vogt, \{M K\} and Viktor Bonkowsky and P Ambrosch and M Scholz and A Neiss and J Strutz and M Hennig and T Lenarz and W Arnold",

year = "2001",

doi = "10.1016/S0959-8049(00)00360-9",

language = "English",

volume = "37",

pages = "2--31",

journal = "EUROPEAN JOURNAL OF CANCER ",

issn = "0959-8049",

publisher = "Elsevier ",

number = "1",

}

Steuer-Vogt, MK, Bonkowsky, V, Ambrosch, P, Scholz, M, Neiss, A, Strutz, J, Hennig, M, Lenarz, T & Arnold, W 2001, 'The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.', EUROPEAN JOURNAL OF CANCER , vol. 37, no. 1, pp. 2-31. https://doi.org/10.1016/S0959-8049(00)00360-9

The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. / Steuer-Vogt, M K; Bonkowsky, Viktor (Co-author); Ambrosch, P et al.
In: EUROPEAN JOURNAL OF CANCER , Vol. 37, No. 1, 2001, p. 2-31.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial.

AU - Steuer-Vogt, M K

AU - Bonkowsky, Viktor

AU - Ambrosch, P

AU - Scholz, M

AU - Neiss, A

AU - Strutz, J

AU - Hennig, M

AU - Lenarz, T

AU - Arnold, W

PY - 2001

Y1 - 2001

KW - GALACTOSIDE-SPECIFIC LECTIN

KW - BETA-ENDORPHIN RELEASE

KW - ALTERNATIVE MEDICINE

KW - COMPLEMENTARY/ALTERNATIVE MEDICINE

KW - LYMPHOCYTE SUBSETS

KW - EXTRACT

KW - CELLS

KW - CARCINOMAS

KW - PREVALENCE

KW - MEDIATE

U2 - 10.1016/S0959-8049(00)00360-9

DO - 10.1016/S0959-8049(00)00360-9

M3 - Original Article

C2 - 11165126

SN - 0959-8049

VL - 37

SP - 2

EP - 31

JO - EUROPEAN JOURNAL OF CANCER

JF - EUROPEAN JOURNAL OF CANCER

IS - 1

ER -

Steuer-Vogt MK, Bonkowsky V, Ambrosch P, Scholz M, Neiss A, Strutz J et al. The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial. EUROPEAN JOURNAL OF CANCER . 2001;37(1):2-31. doi: 10.1016/S0959-8049(00)00360-9